Development of Novel Oncolytic Vector Based on Alternative Adenovirus Serotype 6 for Glioblastoma and Breast Cancer Therapy

被引：0
|
作者：
Romanenko, Margarita [1 ,2 ]
Osipov, Ivan [2 ]
Kutseikin, Sergei [2 ]
Sizova, Mariia [2 ]
Paramonik, Anastasiya [2 ]
Grazhdantseva, Antonina [3 ]
Kochneva, Galina [3 ]
Davydova, Julia [1 ]
Netesov, Sergey [2 ]
机构：
[1] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA
[2] Novosibirsk State Univ, Novosibirsk, Russia
[3] State Res Ctr Virol & Biotechnol Vector, Koltsov, Russia
来源：
MOLECULAR THERAPY | 2021年 / 29卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
10
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [21] Development of PEGylated Adenovirus Vector for Cancer Gene Therapy
    Eto, Yusuke
    Yoshioka, Yasuo
    Asavatanabodee, Ratima
    Mizuguchi, Hiroyuki
    Mukal, Yohei
    Nakagawa, Shinsaku
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2008, 128 (12): : 1733 - 1742
  • [22] Oncolytic Adenovirus Expressing NIS for the Therapy of Chemoresistant Breast Cancer Stem Cells
    Robert, Sacha
    Roman, Natasha I.
    Jacobsen, Kari
    Romanenko, Margarita V.
    Inoko, Kazuho
    Wilber, Stacey
    Lyadov, Daniel
    LaRocca, Christopher J.
    Ostrander, Julie
    Davydova, Julia
    MOLECULAR THERAPY, 2023, 31 (04) : 299 - 300
  • [23] Development of a Targeted Gene Vector Platform Based on Simian Adenovirus Serotype 24
    Belousova, Natalya
    Mikheeva, Galina
    Xiong, Chiyi
    Soghomonian, Suren
    Young, Daniel
    Le Roux, Lucia
    Naff, Katherine
    Bidaut, Luc
    Wei, Wei
    Li, Chun
    Gelovani, Juri
    Krasnykh, Victor
    JOURNAL OF VIROLOGY, 2010, 84 (19) : 10087 - 10101
  • [24] Characterizing an oncolytic adenovirus modified with the CXCL12 ligand for breast cancer therapy
    O'Bryan, Samia M.
    Mathis, J. Michael
    CANCER RESEARCH, 2019, 79 (13)
  • [25] A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy
    Post, DE
    Van Meir, EG
    ONCOGENE, 2003, 22 (14) : 2065 - 2072
  • [26] A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy
    Dawn E Post
    Erwin G Van Meir
    Oncogene, 2003, 22 : 2065 - 2072
  • [27] Preclinical assessment of efficacy and safety of novel oncolytic adenovirus for therapy of disseminated lung cancer
    Atasheva, Svetlana
    Yao, Jia
    Young, Cedrick
    Di Paolo, Nelson C.
    Wyche, Henry
    Shayakhmetov, Dmitry M.
    CANCER RESEARCH, 2019, 79 (13)
  • [28] DEVELOPMENT OF A NOVEL CO-CULTURE MODEL OF GLIOBLASTOMA NEUROSPHERES WITH AUTOLOGOUS PERIPHERAL BLOOD MONONUCLEAR CELLS TO INVESTIGATE THE EFFICACY OF ONCOLYTIC ADENOVIRUS THERAPY
    Stavrakaki, E.
    van den Bossche, W. B. L.
    Vogelezang, L. B.
    Teodosio, C.
    van Dongen, J. J. M.
    Dirven, C. M. F.
    Balvers, R. K.
    Lamfers, M. L.
    NEURO-ONCOLOGY, 2023, 25
  • [29] Development of Novel Therapy for Gastric Cancer Using Oncolytic Reovirus
    Mori, Yoshinori
    Kataoka, Hiromi
    Tanaka, Mamoru
    Ebi, Masahide
    Mizoshita, Tsutomu
    Tanida, Satoshi
    Kamiya, Takeshi
    Johnston, Randal N.
    Joh, Takashi
    DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (11) : 2732 - 2733
  • [30] Development of a novel simian adenovirus 24 based vaccine vector
    Abbink, P.
    Bradley, R. R.
    Ball, F.
    Ng'ang'a, D.
    Borducchi, E.
    Barouch, D. H.
    RETROVIROLOGY, 2012, 9
12345